Close
  Indian J Med Microbiol
 

Figure 2: Effect of myricetin on the mitochondrial transmembrane potential of rotenone-induced MES23.5 cells detected by flow cytometry. (A) Fluorometric assay of mitochondrial transmembrane potential. (B) Quantitative results of mitochondrial transmembrane potential. Rotenone (400 nM) treatment for 24 hours decreased mitochondrial transmembrane potentials compared with controls. Pretreatment with 1 × 10–6 M myricetin for 1 hour prevented the reduction of mitochondrial transmembrane potential reduction induced by rotenone. Data are presented as mean ± SD of eight independent experiments. ***P < 0.001, vs. control group; #P < 0.05, vs. rotenone group (one-way analysis of variance followed by post hoc Tukey’s test).

Figure 2: Effect of myricetin on the mitochondrial transmembrane potential of rotenone-induced MES23.5 cells detected by flow cytometry. 
(A) Fluorometric assay of mitochondrial transmembrane potential. (B) Quantitative results of mitochondrial transmembrane potential. Rotenone (400 nM) treatment for 24 hours decreased mitochondrial transmembrane potentials compared with controls. Pretreatment with 1 × 10<sup>–6</sup> M myricetin for 1 hour prevented the reduction of mitochondrial transmembrane potential reduction induced by rotenone. Data are presented as mean ± SD of eight independent experiments. ***<i>P</i> < 0.001, <i>vs</i>. control group; #<i>P</i> < 0.05, <i>vs</i>. rotenone group (one-way analysis of variance followed by <i>post hoc</i> Tukey’s test).